Literature DB >> 3587891

Orbital recurrence of retinoblastoma.

J Hungerford, J Kingston, N Plowman.   

Abstract

There were 16 cases of orbital recurrence in a consecutive series of 317 children with retinoblastoma referred to a specialist centre. The incidence of orbital relapse amongst children treated at the centre from the outset of their disease was 2.5%. In every case the patient was the first affected family member. The ocular tumour was therefore not anticipated and had commonly been detected at an advanced stage. Systemic staging investigations detected extraorbital spread in six of the 16 and none of these children survived. One of the remaining ten children with no evidence of dissemination at the time of diagnosis of orbital recurrence is a long-term survivor. No child survived after orbital exenteration or radical orbital radiotherapy alone. Three children received a combination of radiotherapy and adjuvant chemotherapy. Only one of the three was free from systemic disease at relapse and this child is the only survivor. In children apparently free from widespread retinoblastoma at diagnosis of orbital recurrence, distant relapse was the commonest cause of death though several children died from direct intracranial extension. It is advocated that orbital recurrence of retinoblastoma is treated by excision biopsy of the tumour mass followed by radical orbital radiotherapy to a dose of 50 Gy. This should be combined with adjuvant chemotherapy and, where a risk of direct intracranial extension exists, by neuraxis irradiation. No other child in this series with evidence of local extraocular extension of retinoblastoma at enucleation and who had received radical orbital radiotherapy to a full dose of 50 Gy subsequently recurred in the orbit.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 3587891     DOI: 10.3109/13816818709028518

Source DB:  PubMed          Journal:  Ophthalmic Paediatr Genet        ISSN: 0167-6784


  11 in total

Review 1.  Chemotherapy for retinoblastoma: a current topic.

Authors:  P T Finger; G Czechonska; H Demirci; A Rausen
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Local extraocular extension of retinoblastoma following intraocular surgery.

Authors:  K E Stevenson; J Hungerford; A Garner
Journal:  Br J Ophthalmol       Date:  1989-09       Impact factor: 4.638

3.  The National Registry of Retinoblastoma in Japan (1983-2014).

Authors: 
Journal:  Jpn J Ophthalmol       Date:  2018-05-30       Impact factor: 2.447

4.  Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.

Authors:  Nicolas Alessandro Yannuzzi; Jasmine H Francis; Brian P Marr; Irina Belinsky; Ira J Dunkel; Yves Pierre Gobin; David Harold Abramson
Journal:  JAMA Ophthalmol       Date:  2015-09       Impact factor: 7.389

5.  Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma.

Authors:  E Ferrari Marback; V E A Arias; A Paranhos; F A Soares; A L Murphree; C M Erwenne
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

Review 6.  Current management strategies for intraocular retinoblastoma.

Authors:  Jonathan W Kim; David H Abramson; Ira J Dunkel
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Orbital retinoblastoma: Present status and future challenges - A review.

Authors:  Mohammad J Ali; Santosh G Honavar; Vijay A P Reddy
Journal:  Saudi J Ophthalmol       Date:  2010-10-13

8.  Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival.

Authors:  B M Sanders; G J Draper; J E Kingston
Journal:  Br J Ophthalmol       Date:  1988-08       Impact factor: 4.638

Review 9.  Orbital retinoblastoma: An update.

Authors:  Santosh G Honavar; Fairooz P Manjandavida; Vijay Anand P Reddy
Journal:  Indian J Ophthalmol       Date:  2017-06       Impact factor: 1.848

10.  Pars Plana Vitrectomy and Evisceration Resulting in Death Due to Misdiagnosis of Retinoblastoma in Children: A Review of 3 Cases.

Authors:  Tao Shen; Rongjiao Liu; Jing Lin; Huiqun Huang; Xiuling Li; Jianhua Yan
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.